Edgemont Home
Healthcare Merchant Banking

Our Transaction Experience

• Mergers, Acquisitions, Divestitures and Restructurings
• Equity and Debt Capital Raising
• Venture Capital
• Strategic Alliances




Novella

PSKW
Tillotts
Celerity
Alliance

 Permier
ValueMedics
California
Lineberry
Medpointe
azur










 






Mergers, Acquisitions Divestitures and Restructurings

  • Sale of Prologue Research International, an oncology-focused contract research organization, to Novella Clinical

  • Acquisition of Triax Media Group, a healthcare marketing and communications company, by PSKW & Associates

  • Sale of Tillotts Pharma, a specialty pharmaceutical company, to Zeria Pharmaceutical

  • Acquisition of Synteract, a contract research organization, by Gryphon Investors

  • Acquisition of Vince and Associates Clinical Research, a clinical services business, by Gryphon Investors

  • Sale of equity interest in Vince and Associates Clinical Research, a clinical services business, to Celerity Partners

  • Sale of Alliance Healthcare Information, a healthcare communications and medical affairs company, to United Drug

  • Sale of ARS Clinical Research, a contract research and data management business, to Premier Research Group

  • Sale of ValueMedics Research, a healthcare research and consulting firm, to IMS Health

  • Sale of California Clinical Trials, a clinical services business, to PAREXEL International

  • Sale of Lineberry Research Associates, a contract research organization, to Constella Group

  • Acquisition of Gastrocrom, UCB's pharmaceutical product, by Azur Pharma and Burren Pharmaceuticals

  • Sale of Nascobal, Questcor Pharmaceutical’s product line to
    QOL Medical

  • Licensing of oxcarbazepine MR, Desitin Arzneimittel’s late-stage CNS pharmaceutical product to a leading U.S. specialty pharmaceuticals company

  • Sale of the Twinject, Hollister-Stier Laboratories’ allergy product, to Verus Pharmaceuticals

  • Sale of MedSN, a pharmaceutical education and marketing company, to Indegene

  • Product valuation, license structuring and strategic / financial advisory services to Anosys, Inc.

  • Licensing MT-300, POZEN’s pharmaceutical product line, to Xcel Pharmaceuticals

  • Sale of Nascobal, Nastech Pharmaceutical Company’s pharmaceutical product line, to Questcor Pharmaceuticals

  • Sale of PharmAnalysis Group, a provider of reimbursement support services, to United Biosource Corporation

  • Strategic and financial advisory to Scion Companies / Prasco, a private specialty pharmaceutical company

  • Acquisition of Doral, MedPointe's pharmaceutical product, by Questcor Pharmaceuticals
  • Strategic and financial advisory to Simstar Internet Solutions, a pharmaceutical marketing services company

  • Sale of CroMedica International, a Central Nervous Systems drug development contract research organization, to PRA International

  • Acquisition of Richwood Pharmaceuticals by Shire Pharmaceuticals, a public U.K. based pharmaceutical company *

  • Acquisition of Pharmavene by Shire Pharmaceuticals, a public U.K. based pharmaceutical company *

  • Sale of Warner Chilcott, Warner Lambert’s generic pharmaceuticals business, to a buyout group *

  • Sale of Quinton division of American Home Products, a leading cardiac testing equipment manufacturer, to a buyout group *

  • Sale of Clinsoft (Domain Pharma), a clinical trials data management software provider to PhaseForward *

  • Sale of Kelly Waldron & Co., a pharmaceutical marketing services provider, to McKesson *

  • Acquisition of Kelly Waldron, a pharmaceutical marketing services provider, by McKesson *

  • Acquisition of SFA, a technology company focused on pharmaceutical sales force automation, by McKesson *

  • Sale of Healthworld, a leader pharmaceutical marketing services provider, to Cordiant Communications *

  • Sale of Covance’s biomanufacturing division to Akzo Nobel *

  • Sale of Worldwide Clinical Trials, a leading Central Nervous Systems drug development contract research organization, to the Ingenix division of United Health Group *

  • Sale of Horizon Systems, a pharmaceutical sales data integration firm, to Acxiom Corporation *

  • Sale of Storz Ophthalmic division of American Home Products, a leading ophthalmology equipment manufacturer, to Bausch & Lomb *

  • Merger of Behring Diagnostics division of Bayer, Inc. with Dade Corporation *

  • Acquisition of HBOC, the largest healthcare information technology provider, by McKesson *

  • Recapitalization of stock and assets to form iMcKesson, LLC by McKesson *

  • Sale of Medstat, a health claims data company, to Thomson Corporation*

  • Acquisition of Medivation, an Internet company focused on structured clinical messaging, by McKesson *

  • Acquisition of Prospective Health, a technology company focused on electronic transaction software, by McKesson *

  • Acquisition of Abaton.com, an Internet company focused on clinical connectivity, by McKesson *

  • Divestiture of McKesson Water Products division of McKesson to Group Danone *

  • Sale of US Servis, a public healthcare information technology company, to HBOC *

  • Sale and Recapitalization of Hemophilia Resources of America (HRA), a hemophilia factor and supplies specialty pharmacy distributor, with Summit Partners *

  • Acquisition of OCMCS by FPA Medical Management, a public physician practice management company *

  • Sale of Physicians Corp. of America (PCA), a physician practice management company, to Humana *

  • Acquisition of Preferred Provider of Michigan (PPOM) by Blue Cross Blue Shield of Michigan *

  • Leveraged buy-out of Healthcare Direct, a leading mail order personal and health products company, by an investor group *



back to top



Equity & Debt Capital Raising

  • Valuation and financial advisory services for Xanodyne Pharmaceuticals, Inc. in connection with its Series C financing

  • Co-Manager, U.S. IPO for Shire Pharmaceuticals, a public U.K. based pharmaceutical company *

  • Co-Lead Manager, acquisition debt facility for Medpointe, a new company formed by senior pharmaceutical industry managers, The Carlyle Group and The Cypress Group to acquire the Carter Wallace pharmaceutical business *

  • Co-Agent Fixed Rate Swap for Medpointe *

  • Sole agent, $25 million private placement for BattellePharma, a drug delivery company *

  • Co-Manager, $2 billion Senior Notes Offering for American Home Products, a leading pharmaceuticals manufacturer *

  • Co-Manager, Follow-on Offering for Marquette Medical Systems, a leading capital diagnostic equipment manufacturer *

  • Co-Manager, Initial Public Offering, Physio-Control Corporation, the leading manufacturer of cardiac defibrillators *

  • Lead Manager, $150 million senior notes for Cardinal Health, the leading pharmaceutical distribution company *

  • Co-Manager, Follow-on Offering for Amerisource, a leading pharmaceutical distribution company *

  • Joint-Book Running Manager, $375 million senior subordinated notes issue for Omnicare, the leading institutional pharmacy company *

  • Co-agent, $495 million bank facility for Omnicare *

  • Lead Manager, Initial Public Offering for Boron, Lepore & Co., a leading pharmaceutical sales and marketing services company *

  • Lead Manager, Follow-on Offering for Boron, Lepore & Co. *

  • Lead Manager, Follow-on Offering for Quality Systems, a physician practice management software provider *

  • Comfort Letter, IPO for Mecon, a healthcare information technology company *

  • Lead Manager, Initial Public Offering for Access Worldwide, a pharmaceutical sales, marketing and fulfillment services provider *

  • Lead Agent, stock repurchase program for Quintiles Transnational, the leading CRO *

  • Sole Agent, block trade for Pharmaceutical Product Development Inc., a leading CRO *

  • Lead Manger, Follow-on Offering for Medcath, operator of specialized heart hospitals *

  • Lead Manager, $75 million convertible debentures for Penn Treaty Corp., the leading independent long term care insurance provider *

back to top



Venture Capital

  • Venture investment in WebMD and subsequent liquidation of position in the public equity market *

  • Venture investment in Pharsight, a pharmaceutical services company focused on clinical trial simulation software *

  • Venture investment in WellMed, an Internet company focused on personal medical records *

  • Venture investment in AvantGo, a technology company focused on middleware for mobile Internet devices *

  • Investment in Mediconsult.com, an Internet company focused on pharmaceutical marketing *

back to top



Strategic Alliances

  • Joint Venture with AvantGo, a technology company focused on middleware for mobile Internet devices *

  • Strategic partnership with Mediconsult.com, an Internet company focused on pharmaceutical marketing *

  • Technology partnership and equity stake in Claimsnet.com, an Internet company focused on electronic transactions *

back to top

* Transaction executed by principals while with other firms.


 
Home      Who We Are      What We Do      Why Work With Us      Our Transaction Experience      In The Press      Contact Us
© 2010 Edgemont Capital Partners, L.P. All Rights Reserved.


Contact Edgemont Edgemont Home